Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Aprea Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −5 vs. Q1 2022
- Shares held
- 2.03M
- −335.8K (−14.2%) vs. Q1 2022
- Total value
- $1.52M
- −$2.89M (−65.5%) vs. Q1 2022
- New holders
- 4
- 11 more added
- Sold out
- 9
- 11 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.90M |
| Q1 2026 | 22 | $1.71M |
| Q4 2025 | 22 | $1.45M |
| Q3 2025 | 23 | $2.39M |
| Q2 2025 | 23 | $3.07M |
| Q1 2025 | 26 | $3.78M |
| Q4 2024 | 26 | $6.83M |
| Q3 2024 | 22 | $5.50M |
| Q2 2024 | 28 | $8.48M |
| Q1 2024 | 24 | $10.8M |
| Q4 2023 | 20 | $4.36M |
| Q3 2023 | 21 | $3.66M |
| Q2 2023 | 19 | $2.78M |
| Q1 2023 | 18 | $3.77M |
| Q4 2022 | 25 | $521.3K |
| Q3 2022 | 27 | $1.11M |
| Q2 2022 | 34 | $1.52M |
| Q1 2022 | 40 | $4.50M |
| Q4 2021 | 41 | $10.4M |
| Q3 2021 | 39 | $25.6M |
| Q2 2021 | 50 | $31.9M |
| Q1 2021 | 67 | $45.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Aprea Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 355,490 | $266.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 351,836 | $264.0K | 0.00% | +104,892+42.5% | Added |
| Renaissance Technologies LLC | 311,754 | $234.0K | 0.00% | +13,854+4.7% | Added |
| BlackRock Inc. | 186,779 | $140.0K | 0.00% | −43,386−18.8% | Reduced |
| Geode Capital Management, LLC | 150,142 | $111.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 71,959 | $54.0K | 0.00% | +71,959 | New |
| Susquehanna International Group, LLP | 61,957 | $46.0K | 0.00% | −49,412−44.4% | Reduced |
| Two Sigma Investments, LP | 60,383 | $45.0K | 0.00% | +41,773+224.5% | Added |
| D. E. Shaw & Co., Inc. | 49,750 | $37.0K | 0.00% | +32,866+194.7% | Added |
| Crestline Management, LP | 48,819 | $36.0K | 0.00% | −632−1.3% | Reduced |
| Tower Research Capital LLC (TRC) | 47,362 | $36.0K | 0.00% | +13,931+41.7% | Added |
| Bridgeway Capital Management, LLC | 45,000 | $33.0K | 0.00% | −15,000−25.0% | Reduced |
| State Street Corp | 40,832 | $30.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 32,803 | $24.0K | 0.00% | −20,301−38.2% | Reduced |
| Northern Trust Corp | 28,710 | $22.0K | 0.00% | −495−1.7% | Reduced |
| Verition Fund Management LLC | 20,101 | $15.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 19,664 | $15.0K | 0.00% | +5,829+42.1% | Added |
| The PNC Financial Services Group, Inc. | 20,000 | $15.0K | 0.00% | +20,000 | New |
| Citadel Advisors LLC | 18,881 | $14.0K | 0.00% | −58,201−75.5% | Reduced |
| Bank of New York Mellon Corp | 16,643 | $12.0K | 0.00% | −60−0.4% | Reduced |
| Blackstone Group Inc. | 16,590 | $12.0K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 14,700 | $11.0K | 0.00% | +14,700 | New |
| Quantamental Technologies LLC | 11,352 | $9.00K | 0.00% | −1,400−11.0% | Reduced |
| Advisor Group Holdings, Inc. | 11,628 | $9.00K | 0.00% | +10,578+1,007.4% | Added |
| Stifel Financial Corp | 10,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10,332 | $8.00K | 0.00% | +5,072+96.4% | Added |
| Millennium Management LLC | 10,255 | $8.00K | 0.00% | +10,255 | New |
| Sugarloaf Wealth Management, LLC | 5,000 | $4.00K | 0.00% | +3,500+233.3% | Added |
| Federated Hermes, Inc. | 3,691 | $3.00K | 0.00% | +137+3.9% | Added |
| JPMorgan Chase & Co | 4 | $0 | 0.00% | −29,505−100.0% | Reduced |
| Bank of America Corp | 198 | $0 | 0.00% | −3,985−95.3% | Reduced |
| Kistler-Tiffany Companies, LLC | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 607 | $0 | 0.00% | +511+532.3% | Added |
| Quent Capital, LLC | 75 | $0 | 0.00% | 00.0% | Unchanged |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −334,796−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −29,447−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −29,109−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −20,572−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −20,570−100.0% | Sold out |
| Magnus Financial Group LLC | 0 | $0 | 0.00% | −14,856−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −11,700−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,773−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |